PL2726064T3 - Doustna postać użytkowa o kontrolowanym uwalnianiu zawierająca oksykodon - Google Patents
Doustna postać użytkowa o kontrolowanym uwalnianiu zawierająca oksykodonInfo
- Publication number
- PL2726064T3 PL2726064T3 PL12732541T PL12732541T PL2726064T3 PL 2726064 T3 PL2726064 T3 PL 2726064T3 PL 12732541 T PL12732541 T PL 12732541T PL 12732541 T PL12732541 T PL 12732541T PL 2726064 T3 PL2726064 T3 PL 2726064T3
- Authority
- PL
- Poland
- Prior art keywords
- oxycodone
- dosage form
- controlled release
- oral dosage
- release oral
- Prior art date
Links
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title 1
- 238000013270 controlled release Methods 0.000 title 1
- 239000006186 oral dosage form Substances 0.000 title 1
- 229960002085 oxycodone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11005365 | 2011-06-30 | ||
| EP12732541.3A EP2726064B1 (en) | 2011-06-30 | 2012-06-29 | Controlled release oral dosage form comprising oxycodone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2726064T3 true PL2726064T3 (pl) | 2017-06-30 |
Family
ID=45002176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12732541T PL2726064T3 (pl) | 2011-06-30 | 2012-06-29 | Doustna postać użytkowa o kontrolowanym uwalnianiu zawierająca oksykodon |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9387166B2 (pl) |
| EP (1) | EP2726064B1 (pl) |
| ES (1) | ES2616115T3 (pl) |
| HU (1) | HUE031251T2 (pl) |
| PL (1) | PL2726064T3 (pl) |
| PT (1) | PT2726064T (pl) |
| WO (1) | WO2013000578A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102082529B1 (ko) | 2012-04-17 | 2020-02-27 | 퍼듀 퍼머 엘피 | 오피오이드-유도 유해 약역학 반응을 치료하기 위한 시스템 및 방법 |
| EP2872121B1 (en) | 2012-07-12 | 2018-09-05 | SpecGx LLC | Extended release, abuse deterrent pharmaceutical compositions |
| CA3042642A1 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| WO2015120201A1 (en) | 2014-02-05 | 2015-08-13 | Kashiv Pharma, Llc | Abuse-resistant drug formulations with built-in overdose protection |
| CA2955229C (en) | 2014-07-17 | 2020-03-10 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
| AU2015336065A1 (en) | 2014-10-20 | 2017-05-04 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5266331A (en) | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
| IL110014A (en) | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| WO2003092648A1 (en) | 2002-04-29 | 2003-11-13 | Alza Corporation | Methods and dosage forms for controlled delivery of oxycodone |
| CA2487786A1 (en) * | 2002-05-31 | 2003-12-11 | Alza Corporation | Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
| CA2541371C (en) * | 2003-10-03 | 2014-12-16 | Atul M. Mehta | Extended release formulations of opioids and method of use thereof |
| CA2570503A1 (en) * | 2004-06-17 | 2005-12-29 | Osteologix A/S | A method of improving the medical treatment of pain |
| PL2187876T3 (pl) | 2007-09-21 | 2013-01-31 | Evonik Roehm Gmbh | Farmaceutyczna kompozycja opioidowa o zależnym od pH kontrolowanym uwalnianiu z odpornością przed wpływem etanolu |
-
2012
- 2012-06-29 US US14/129,265 patent/US9387166B2/en not_active Expired - Fee Related
- 2012-06-29 PL PL12732541T patent/PL2726064T3/pl unknown
- 2012-06-29 WO PCT/EP2012/002739 patent/WO2013000578A1/en not_active Ceased
- 2012-06-29 EP EP12732541.3A patent/EP2726064B1/en active Active
- 2012-06-29 ES ES12732541.3T patent/ES2616115T3/es active Active
- 2012-06-29 HU HUE12732541A patent/HUE031251T2/en unknown
- 2012-06-29 PT PT127325413T patent/PT2726064T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140377349A1 (en) | 2014-12-25 |
| WO2013000578A1 (en) | 2013-01-03 |
| ES2616115T3 (es) | 2017-06-09 |
| EP2726064A1 (en) | 2014-05-07 |
| HUE031251T2 (en) | 2017-07-28 |
| US9387166B2 (en) | 2016-07-12 |
| EP2726064B1 (en) | 2016-09-21 |
| PT2726064T (pt) | 2016-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201307862B (en) | Controlled release pharmaceutical dosage forms | |
| IL227383A0 (en) | Extended-release oral dosage forms containing tsucitinib | |
| ZA201304158B (en) | Dosage form | |
| PT3653223T (pt) | Dispositivo para a entrega oral de compostos terapêuticos | |
| PL2776416T3 (pl) | Związki farmaceutyczne | |
| GB201221017D0 (en) | Prosthodontic device | |
| ZA201402669B (en) | Solution for oral administration | |
| HUE038543T2 (hu) | MGBG-t tartalmazó szabályozott kibocsátású orális gyógyszerészeti dózis-formák | |
| PL2726064T3 (pl) | Doustna postać użytkowa o kontrolowanym uwalnianiu zawierająca oksykodon | |
| GB201119799D0 (en) | Pharmaceutical compounds | |
| IL232392A0 (en) | pharmaceutical compounds | |
| GB201118876D0 (en) | Pharmaceutical compounds | |
| GB201113163D0 (en) | Pharmaceutical compounds | |
| GB201118334D0 (en) | Novel dosage form | |
| PL2683340T3 (pl) | Urządzenie doustne | |
| GB201113730D0 (en) | Solid dosage form | |
| GB201011271D0 (en) | Dosage Form | |
| GB201018917D0 (en) | Dosage form | |
| GB201018760D0 (en) | An oral dosage form | |
| PH32012000576S1 (en) | Design feature for an oral dosage form | |
| PH32012000575S1 (en) | Design feature for an oral dosage form | |
| PH32012000577S1 (en) | Design feature for an oral dosage form | |
| PH32012000578S1 (en) | Design feature for an oral dosage form | |
| GB201102162D0 (en) | Contraceptive compounds | |
| GB201117359D0 (en) | Pharmaceutical compounds |